No insider purchase over the last 90 days. The latest, by Schenk Chris, was filed 05 May 2026.
+2 other insiders
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Ategrity Specialty Insurance Co Holdings Buy (bullish), based on 5 analysts. Average price target: US$29.10.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
15 of 15 declarations
On June 12, 2025, 5 filers bought on the same day at Ategrity Specialty Insurance Co Holdings, for EUR 1,557,195 in total: Robert C. Merton, Director, EUR 689,628, John Langton Sennott Jr., Director, EUR 430,853 and Neelam Patel, Chief Financial Officer, EUR 293,097. Six purchases are marked as clustered. Overall, the 10 purchases in the record, all with an amount, weigh EUR 1.9 million with a median of EUR 94,007, and none of the 13 filings is a sale.
The company, listed on Nasdaq and valued at USD 1.25 billion, published 9 filings in 2025 and 4 in 2026, for trades from June 12, 2025 to June 11, 2026. Stuart J. Zimmer, Director, files 3, all purchases, while William S. Mercer, Robert C. Merton and John Langton Sennott Jr. file 2 each, with 1 purchase. Chris Schenk, listed as See Remarks, filed 1 purchase. The record also holds 3 option exercises. Eight filers appear, and insiders hold 81.4% of the capital.
For 10 purchases the stored 90-day return has a median of -13%, with 30% of cases positive (performance already recorded, not a forecast). The typical gap between trade and publication is 4 days, and 5 filings fall within the past year.